DAFLON 500 mg, film-coated tablet 60 tablets
Brand page: Daflon (diosmin + hesperidin (micronised purified flavonoid fraction)) — all forms and strengths in France
Active ingredients: Diosmin, FRACTION FLAVONOÏQUE PURIFIÉE MICRONISÉE, Hesperidin
Commercialized according to BDPM
Film-coated tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DAFLON 500 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 60 comprimé(s)
- Marketing authorisation holder
- DIFARMED (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 27 Nov 2015
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60064527CIP74900055CIP133400949000555Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DIOSMINEcomprimé | 450 mg · un comprimé | FT |
| HESPÉRIDINEcomprimé | 50 mg · un comprimé | FT |
| FRACTION FLAVONOÏQUE PURIFIÉE MICRONISÉEcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.